CMMB
Chemomab Therapeutics Ltd ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.83
-0.03 ▼ -1.61%
🌙 3월 13일 7:22 PM ET (한국 3/14 08:22)
$1.83
+0.00 +0.25%
| Index | - | P/E | - | EPS (ttm) | -1.86 | Insider Own | 9.98% | Shs Outstand | 0.01B | Perf Week | -2.66% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | -150% | Insider Trans | - | Shs Float | 0.01B | Perf Month | 15.82% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.04 | Inst Own | 5.97% | Short Float | 0.99% | Perf Quarter | -25.91% |
| Income | -0.01B | P/S | - | EPS this Y | 53.49% | Inst Trans | -0.86% | Short Ratio | 0.61 | Perf Half Y | -40% |
| Sales | 0.00B | P/B | 1 | EPS next 5Y | 2.38% | ROA | -60.98% | Short Interest | 0.05M | Perf YTD | 10.91% |
| Book/sh | 1.82 | P/C | 1.1 | EPS past 3/5Y | 13.38% 45.2% | ROE | -73.63% | 52W High | -70% ($6.10) | Perf Year | -67.09% |
| Cash/sh | 1.66 | P/FCF | - | Sales past 3/5Y | - | ROIC | -90.31% | 52W Low | 35.56% ($1.35) | Perf 3Y | -68.23% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 53.19% | Gross Margin | - | Volatility(W/M) | 9.82% 10.76% | Perf 5Y | -99.35% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.18 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.49 | EPS Q/Q | 64.5% | Profit Margin | - | RSI (14) | 52.89 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.49 | Sales Q/Q | - | SMA20 | 5.68% ($1.73) | Beta | 0.52 | Target Price | $15 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 7.57% ($1.7) | Rel Volume | 0.26 | Prev Close | $1.86 |
| Employees | 16 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 60% - | SMA200 | -39.49% ($3.02) | Avg Volume(3M) | 0.09M | Price | $1.83 |
| IPO | 2019/2/12 | Option/Short | No/Yes | Trades | 113 | Volume | 23,302 | Change | -1.61% |
뉴스 로딩 중...